Back to 
Cubist Systematic Strategies, LLC
Cubist Systematic Strategies, LLC
DRNAShowing 0 of 13 quarters
Position history for Cubist Systematic Strategies, LLC's holdings in DICERNA PHARMACEUTICALS INC
As of its Q3 2021 13F, Cubist Systematic Strategies held 58,993 shares of DRNA (Dicerna Pharmaceuticals), worth $1.2M. Cubist Systematic Strategies' 13F filings listed DRNA from Q4 2020 to Q3 2021, 4 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of DRNA: RTW INVESTMENTS, LP